CDC reports 10,772 confirmed Ebola cases and 5234 deaths, making this the second-largest outbreak on record. Kenya and Nigeria have reported cases.
|Articles|April 26, 2016
First Case of Sexually Transmitted Zika Confirmed in Canada
Author(s)Sarah Anwar
The first case of sexually transmitted Zika infection in Canada was confirmed on April 25, 2016 by the Public Health Agency of Canada and the Ontario Ministry of Health and Long-Term Care.
Advertisement
The first case of sexually transmitted Zika infection in Canada was confirmed in an
Zika is a flavivirus spread to humans mainly by the Aedes aegypti, the same mosquito that carries the Chikungunya and Dengue viruses. Once an individual is infected with the virus, he or she can spread the virus to a partner through
The Ontario local contracted the Zika infection after their sexual partner returned from a country with active Zika transmission. After testing at the PHAC National Microbiology Laboratory confirmed Zika infection in the Ontario local, both the PHAC and the MOHLTC assured the public that the Ae. aegypti mosquito is not present within the country (due to the extremely cold climate), and so there is no possibility of local transmission within Canada. Furthermore, it was noted that all previously confirmed cases of Zika infection in Canada were due to travel to areas with active transmission.
The MOHLTC currently conducts laboratory testing for all individuals who show symptoms of the disease, regardless of travel history. Those traveling to areas with active transmission are advised to follow the necessary precautions to avoid infection, especially those who are pregnant or planning to become pregnant, and their partners. Moreover, since Zika can remain in the semen for extended periods of time, the use of condoms during sexual interaction is strongly advised for 6 months after exposure.
Rohit Bhalla, DO, Chief of the Section of Infectious Diseases at the University Medical Center of Princeton, provides information healthcare practitioners should know about diagnosing a Zika virus infection, particularly as the virus moves in the United States.
Advertisement
Related to this article
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
Monthly elebsiran plus tobevibart achieved undetectable HDV RNA with ALT normalization in 44% of patients at week 48 in the pivotal phase 3 ECLIPSE 1 trial.
Deborah Fuller, PhD, provides commentary around the data, and advantages of the technology.
IDSA and ESCMID released 7 consensus statements to assist in managing individuals with SAB. This review will focus on the adult patient population and additional information on pediatric population statements can be assessed in the guideline. Here is a closer look at Consensus Statement 2: Follow-up Blood Cultures.
IDSA and ESCMID released 7 consensus statements to assist in managing individuals with Staphylococcus aureus Bacteremia (SAB). This review will focus on the adult patient population and additional information on pediatric population statements can be assessed in the guideline.
New data from the PETERPEN trial suggest that piperacillin-tazobactam may be noninferior to meropenem for early clinical outcomes in select patients with ESBL bloodstream infections, but carbapenems remain the standard of care until final mortality results are available and fully analyzed.
Recent urinary tract infection guideline updates from multiple international
medical societies highlight evolving recommendations, including a major shift
in classification, moving from anatomy- and risk factor–based definitions
toward distinguishing localized from systemic infections.
Advertisement
Advertisement